Jacob Weston

Unlocking Ketamine: Medicine, Function, and History

To begin my presentation I will be introducing ketamine as a chemical anomaly in the medical field. Following this I will talk about the history of the drug and why it is valuable to know about its use and risks. From this history I will transition into examples of how ketamine is being used in medical practice and how the drug is administered. To continue and add understanding I will then explain the NMDA receptors in our brains and how they interact with the chemical. This will lead to the function of ketamine in the brain covering some effects of the chemical. I will then be talking about the structure of the chemical, explaining how the shape is of integral importance to how ketamine binds to brain receptors. To conclude I will restate that ketamine is a chemical that we don’t fully understand but, despite that, we can learn from it daily to  better understand medicine as a whole. Thank you.

CHEM 121, General Chemistry

Pamela Beilby

Goodrich 109

2:30 – 3 PM

Return to schedule

Joshua McCluskey

Comparing the effects of different classes of medication in the management of hypertension 

The diagnosis of hypertension is common and treatment is frequently viewed as very simple. Treating hypertension takes more than just lowering the blood pressure of an individual. There are comorbidities that affect and are affected by the treatment of hypertension: kidney disease and cardiovascular disease. In this review we discuss the different preferences of using either Angiotensin Converting Enzyme (ACE) inhibitors, Calcium Channel blockers, Beta Blockers, and Diuretics when managing hypertension with the use of medications. It appears that Angiotensin Converting Enzyme (ACE) inhibitors were preferential to the management of kidney disease secondary to hypertension. Calcium channel blockers were additionally found to have an advantage with many cardiovascular diseases while beta blockers were also considered for cardiovascular issues including atrial fibrillation and tachycardia specifically. Beta blockers and Diuretics had minute differences in secondary management of cardiovascular disease and kidney disease when compared. 

CHEM 415, Biochemistry 

Heike McNeil 

P114 

11:30 AM – Noon 

Return to schedule